Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting PANX1/IL-33 axis decreases MRSA infection-induced liver damage

Sep. 17, 2021

Endeavor BioMedicines licenses rights to ULK1/2 inhibitor for LKB1- and RAS-mutated cancers

Sep. 17, 2021

VU-6028418 reverses cataleptic behavior in rat models

Sep. 17, 2021

Novel potent TGR5 agonist shows antidiabetic effects in TGR5(H88Y) mutant mice

Sep. 17, 2021

Nanjing Sanhome Pharmaceutical divulges anti-CD47/anti-PD-L1 antibodies

Sep. 17, 2021

Achillion Pharmaceuticals identifies new complement factor D inhibitors

Sep. 17, 2021

UCL Business describes new CRP inhibitors

Sep. 17, 2021

Bahcesehir Universitesi presents Hdm2 inhibitors

Sep. 17, 2021

Guanylate cyclase C agonist IW-3300 shows promise for treating visceral pain

Sep. 17, 2021

Mitokinin discloses PINK1 activators

Sep. 17, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026